Evaluation of Clinical and Safety Outcomes of Neoadjuvant Immunotherapy Combined With Chemotherapy for Patients With Resectable Esophageal Cancer A Systematic Review and Meta-analysis

Ge, F; Huo, ZY; Cai, XY; Hu, QY; Chen, WH; Lin, G; Zhong, R; You, ZD; Wang, R; Lu, Y; Wang, RC; Huang, QH; Zhang, HT; Song, AQ; Li, CC; Wen, YK; Jiang, Y; Liang, HR; He, JX; Liang, WH; Liu, J

Liang, WH; Liu, J (通讯作者)，Guangzhou Med Univ, Affiliated Hosp 1, Dept Thorac Surg & Oncol, State Key Lab Resp Dis, Guangzhou 510120, Peoples R China.;Liang, WH; Liu, J (通讯作者)，Guangzhou Inst Resp Hlth, Natl Clin Res Ctr Resp Dis, Guangzhou 510120, Peoples R China.

JAMA NETWORK OPEN, 2022; 5 (11):

Abstract

IMPORTANCE A considerable number of clinical trials of neoadjuvant immunotherapy for patients with resectable esophageal cancer are emerging. However,......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索